Related Experiment Video For artificial intelligence
Updated: Jan 11, 2026

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
Published on: September 15, 2023
Computer Vision-Assisted Spatial Analysis of Mitoses and Vasculature in Lung Cancer
Anna Timakova1, Alexey Fayzullin1, Vladislav Ananev2
1Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya St., 119991 Moscow, Russia.
Abstract:
Background/Objectives: Lung cancer is characterized by a significant microstructural heterogenicity among different histological types. Artificial intelligence and digital pathology instruments can facilitate morphological analysis by introducing calculated metrics allowing for the distinguishment of different tissue patterns. Methods: We used computer vision models to calculate a number of morphometric features of tumor vascularization and proliferation. We used two frameworks to process whole-slide images: (1) LVI-PathNet framework for vascular detection, based on the SegFormer architecture; and (2) Mito-PathNet framework for mitotic figure detection, based on the RetinaNet detector and an ensemble classification model. The results were visualized in the segmented and gradient heatmaps. Results: SegFormer for vessel segmentation achieved the following quality metrics: IoU = 0.96, FBeta-score = 0.98, and AUC-ROC = 0.98. RetinaNet + CNN ensemble achieved the following quality metrics: specificity = 0.96 and sensitivity = 0.97. The analysis of the obtained parameters allowed us to identify trophic patterns of lung cancer according to the degree of aggressiveness, which can serve as potential targets for therapy, including proliferative-vascular, hypoxic, proliferative, vascular, and inactive. Conclusions: The analysis of the obtained parameters allowed us to identify distinct quantitative characteristics for each histological type of lung cancer. These patterns could potentially become markers for therapeutic choices, such as antiangiogenic and hypoxia-induced factor therapy.

